Join us at the Society of Toxicology Annual Meeting and ToxExpo
We look forward to connecting with researchers at the Society of Toxicology Annual Meeting
and ToxExpo in Salt Lake City from March 10 to 14.
Find us in Booth #1234.
THYROID MICROTISSUES 
Our cryopreserved primary human thyrocytes, due for market release this spring, will support endocrine disruptor screening. Click here.
HEPATIC SYSTEM 
TruVivo™ is the first and only 2D+ hepatic system to provide human-relevant, reliable results in an easy-to-use format. Click here.
PORTFOLIO 
Did you know we have the largest selection of comprehensively characterized liver cells and tissue in the industry? Click here.
SERVICES 
Talk to our experts about how our cell-based assay services can support your compound discovery and toxicology testing. Click here.
Poster Presentations Featuring our Scientific Experts
Eda Rogers, PhD
Cryopreserved Primary Human Thyrocytes for Discovery and Development of Thyroid Disease Treatments
March 12, 2:15-4:15 p.m. MST
Abstract No.: 4214/Poster No.: P763
James McKim, PhD
Evaluation of a New Meso-Scale MPS Integrated Organ Platform to Evaluate Acetaminophen and Diclofenac Kinetics, Organ Distribution Metabolism, and Cytotoxicity
March 12, 2:15-4:15 p.m. MST
Abstract No.: 4191/Poster No.: P740
Kristina Wolf, PhD
A Novel In Vitro All-Human 2D+ Hepatic System to Evaluate Compound-Induced Fibrogenic Response
March 13, 11:45 a.m.-1:45 p.m. MST
Abstract No.: 4624/Poster No.: P484
Jeff Pregenzer
A Novel Meso-Scale MPS Integrated Organ Platform to Evaluate Usnic Acid Kinetics, Organ Distribution and Cytotoxicity: A Case Study
Session
March 12, 2:15-4:15 p.m. MST
Abstract No.: 4193/Poster No.: P742
Exhibitor-hosted Session Focuses on Pioneering Projects
The Latest Insights in Toxicological Applications from TruVivo™ and a Novel All-Human Thyroid Model
As a pioneering all-human 2D+ hepatic system, TruVivo has been extensively tested for various applications, including hepatic clearance of low-turnover drugs and drug-drug interactions. Now, application-specific data are available for ADME/tox and disease modeling applications. LifeNet Health’s scientists will share the latest insights using TruVivo and offer a sneak peek into the novel in vitro human thyroid microtissue model with hormone competence, developed in partnership with the US EPA.
Presented by Edward LeCluyse, PhD
March 13, 3-4 p.m. MST
Salt Palace Convention Center, Room 155 F